Publications
.
Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB. Proc Natl Acad Sci U S A. 2018 ;115(51):E12053-E12062.
. .
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease. Neurobiol Aging. 2014 ;35(12):2701-2712.
.